CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Sotalol Hydrochloride

· ingredient sotalol· SOTALOL HYDROCHLORIDE 120 mg/1; SOTALOL HYDROCHLORIDE 160 mg/1; SOTALOL HYDROCHLORIDE 240 mg/1; SOTALOL HYDROCHLORIDE 80 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.10388
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other sotalol products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Sotalol$0.07079−$0.03310
Sotalol$0.08733−$0.01650
BETAPACE$0.10388+$0.00000

Medicare Part D coverage · CY2026

On 328 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.